MG starts applying chikungunya vaccine developed by Instituto Butantan
Minas Gerais has begun administering a new chikungunya vaccine developed by Instituto Butantan, designed for adults aged 18 to 59 without immune deficiencies.
A compact global news feed for the bigger picture.
Minas Gerais has begun administering a new chikungunya vaccine developed by Instituto Butantan, designed for adults aged 18 to 59 without immune deficiencies.
Loading Intelligence...
Select a report from the feed to view analysis and related coverage.
A compact global news feed for the bigger picture. It pulls reporting from outlets around the world so you can compare what gets covered, what gets missed, and how it’s framed.
It can feel dense at first (on purpose): more signal, less fluff. No ads. No trackers. No agenda.